Evidence map›Paper›PMID 24482654›Full record

ArticleArchives of medical science : AMS2013

Role of cytological characteristics of benign thyroid nodules on effectiveness of their treatment with levothyroxine.

Mustafa Cesur, Mehtap Akcil, Sibel Ertek, Rifat Emral, Safak Bulut, Sevim Gullu, Demet Corapcioglu

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Thyroid diseases in patients with acromegaly.Archives of medical science : AMS · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mustafa CesurDepartment of Endocrinology and Metabolic Diseases, Ankara Guven Hospital, Ankara, Turkey.
Mehtap AkcilDepartment of Statistics and Computer Science, Baskent University Faculty of Science and Letters, Ankara, Turkey.
Sibel ErtekDepartment of Endocrinology and Metabolism, Medical Faculty, Ufuk University, Ankara, Turkey.
Rifat EmralDepartment of Endocrinology and Metabolic Diseases, Ankara University School of Medicine, Ankara, Turkey.
Safak BulutDepartment of Pathology, Ankara University School of Medicine, Ankara, Turkey.
Sevim GulluDepartment of Endocrinology and Metabolic Diseases, Ankara University School of Medicine, Ankara, Turkey.
Demet CorapciogluDepartment of Endocrinology and Metabolic Diseases, Ankara University School of Medicine, Ankara, Turkey.
Ankara University · TRBaşkent University · TRGüven Hospital · TRUfuk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLevothyroxine (LT4) therapy has been used for the treatment of euthyroid nodular goiter, but there are controversial results about its usefulness. We aimed to evaluate the possible role of benign nodules' cytological characteristics in response to LT4 therapy. MATERIAL AND

methodsIn total, 93 patients with 128 nodules were included in the study; 74 of the nodules were treated with LT4 (group 1), and 54 of them had no medication (group 2). The subgroups consisted of adenomatous nodules, colloid nodules and cystic nodules.

resultsIn group 1, mean thyroid volume and mean nodule volume were reduced significantly (p = 0.002 and p = 0.022, respectively) with low-normal level thyrotropin (TSH) suppression (between 0.3 mIU/ml and 1.0 mIU/ml), while there were no significant changes in group 2. When we evaluated changes of the initial and last nodule volumes in cytological subgroups, only colloid nodules in group 1 had significant reduction (p = 0.040) and the others had no significant changes. By omitting the colloid nodules, when the other nodules were revaluated, there were no significant changes in either group.

conclusionsOn the basis of these results, obtained from a large sample of Anatolian patients, it is possible that LT4 therapy leads to significant reductions of both thyroid volume and nodule size in colloid nodules, but not in other kinds of benign nodules.

Indexed as

adenomatous nodulecolloid nodulecystic nodulecytological featureslevothyroxinelevothyroxine suppressive therapynodule treatmentthyroid nodule

Identifiers

PMID24482654
PMCPMC3902726
OpenAlexW2031969598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.